137 related articles for article (PubMed ID: 17141985)
1. A new amoxicillin/clavulanate therapeutic system: preparation, in vitro and pharmacokinetic evaluation.
Kerč J; Opara J
Int J Pharm; 2007 Apr; 335(1-2):106-113. PubMed ID: 17141985
[TBL] [Abstract][Full Text] [Related]
2. Relative Oral Bioavailability of Two Amoxicillin-Clavulanic Acid Formulations in Healthy Dogs: A Pilot Study.
Moczarnik J; Berger DJ; Noxon JO; LeVine DN; Lin Z; Coetzee JF; Mochel JP
J Am Anim Hosp Assoc; 2019; 55(1):14-22. PubMed ID: 30427713
[TBL] [Abstract][Full Text] [Related]
3. Amoxicillin/clavulanic acid (875/125): bioequivalence of a novel Solutab tablet and rationale for a twice-daily dosing regimen.
Sourgens H; Bertola MA; Verschoor JS; Kuipers M; Rayer B
Int J Clin Pharmacol Ther; 2004 Mar; 42(3):165-73. PubMed ID: 15049437
[TBL] [Abstract][Full Text] [Related]
4. Oral bioavailability and pharmacokinetic profile of the amoxicillin-clavulanic acid combination after intravenous and oral gavage administration in broiler chickens.
Jerzsele A; Nagy G; Lehel J; Semjen G
J Vet Pharmacol Ther; 2009 Oct; 32(5):506-9. PubMed ID: 19754920
[No Abstract] [Full Text] [Related]
5. Oral bioavailability and pharmacokinetic profile of the amoxicillin-clavulanic acid combination after intravenous and oral administration in Turkeys.
Jerzsele A; Nagy G; Semjen G
J Vet Pharmacol Ther; 2011 Apr; 34(2):202-5. PubMed ID: 21395615
[No Abstract] [Full Text] [Related]
6. Variable absorption of clavulanic acid after an oral dose of 25 mg/kg of Clavubactin and Synulox in healthy dogs.
Vree TB; Dammers E; Van Duuren E
J Vet Pharmacol Ther; 2003 Jun; 26(3):165-71. PubMed ID: 12755899
[TBL] [Abstract][Full Text] [Related]
7. Identical pattern of highly variable absorption of clavulanic acid from four different oral formulations of co-amoxiclav in healthy subjects.
Vree TB; Dammers E; Exler PS
J Antimicrob Chemother; 2003 Feb; 51(2):373-8. PubMed ID: 12562705
[TBL] [Abstract][Full Text] [Related]
8. Bioavailability of amoxicillin and clavulanic acid from extended release tablets depends on intragastric tablet deposition and gastric emptying.
Weitschies W; Friedrich C; Wedemeyer RS; Schmidtmann M; Kosch O; Kinzig M; Trahms L; Sörgel F; Siegmund W; Horkovics-Kovats S; Schwarz F; Raneburger J; Mönnikes H
Eur J Pharm Biopharm; 2008 Oct; 70(2):641-8. PubMed ID: 18582572
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of the amoxicillin-clavulanic acid combination after intravenous and oral administration in cats.
Yang F; Yang F; Wang G; Xi W; Zhang C; Wang H
J Vet Pharmacol Ther; 2019 Sep; 42(5):511-517. PubMed ID: 31162674
[TBL] [Abstract][Full Text] [Related]
10. The bioavailability and pharmacokinetics of an amoxicillin-clavulanic acid granular combination after intravenous and oral administration in swine.
Sun P; Zhao T; Xiao H; Wang J; Zhang S; Cao X
J Vet Pharmacol Ther; 2021 Jan; 44(1):126-130. PubMed ID: 33063331
[TBL] [Abstract][Full Text] [Related]
11. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
Chen C; Bujanover S; Kareht S; Rapoport AM
Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
[TBL] [Abstract][Full Text] [Related]
12. Comparative in vitro activity of a pharmacokinetically enhanced oral formulation of amoxicillin/clavulanic acid (2000/125 mg twice daily) against 9172 respiratory isolates collected worldwide in 2000.
Koeth LM; Jacobs MR; Good CE; Bajaksouzian S; Windau A; Jakielaszek C; Saunders KA
Int J Infect Dis; 2004 Nov; 8(6):362-73. PubMed ID: 15494258
[TBL] [Abstract][Full Text] [Related]
13. Non-linear absorption pharmacokinetics of amoxicillin: consequences for dosing regimens and clinical breakpoints.
de Velde F; de Winter BC; Koch BC; van Gelder T; Mouton JW;
J Antimicrob Chemother; 2016 Oct; 71(10):2909-17. PubMed ID: 27330071
[TBL] [Abstract][Full Text] [Related]
14. Susceptibility patterns for amoxicillin/clavulanate tests mimicking the licensed formulations and pharmacokinetic relationships: do the MIC obtained with 2:1 ratio testing accurately reflect activity against beta-lactamase-producing strains of Haemophilus influenzae and Moraxella catarrhalis?
Pottumarthy S; Sader HS; Fritsche TR; Jones RN
Diagn Microbiol Infect Dis; 2005 Nov; 53(3):225-31. PubMed ID: 16257168
[TBL] [Abstract][Full Text] [Related]
15. Bioequivalence study of two commercial amoxicillin suspension formulations in healthy human volunteers.
Franco GC; Baglie S; Ruenis AP; Franco LM; Cogo K; Oshima-Franco Y; Silva P; Groppo FC; Rosalen PL
Int J Clin Pharmacol Ther; 2014 May; 52(5):425-30. PubMed ID: 24755132
[TBL] [Abstract][Full Text] [Related]
16. Is the demonstration of bioequivalence for clavulanic acid required in amoxicillin-clavulanic acid orally administered immediate-release products?
Charoo NA; Rahman Z; Ali AA
J Pharm Pharmacol; 2018 Jul; 70(7):883-892. PubMed ID: 29633270
[TBL] [Abstract][Full Text] [Related]
17. Impact of high-flux haemodialysis on the probability of target attainment for oral amoxicillin/clavulanic acid combination therapy.
Hui K; Patel K; Kong DCM; Kirkpatrick CMJ
Int J Antimicrob Agents; 2017 Jul; 50(1):110-113. PubMed ID: 28502697
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics and Drug Residue in Eggs After Multiple-Day Oral Dosing of Amoxicillin-Clavulanic Acid in Domestic Chickens.
Shannon L; Cox SK; Bailey J; Fortner C; Davis R; Gerhardt L; Souza MJ
J Avian Med Surg; 2020 Mar; 34(1):3-8. PubMed ID: 32237676
[TBL] [Abstract][Full Text] [Related]
19. Variable absorption of clavulanic acid after an oral dose of 25 mg/kg of Clavubactin and Synulox in healthy cats.
Vree TB; Dammers E; van Duuren E
ScientificWorldJournal; 2002 May; 2():1369-78. PubMed ID: 12805922
[TBL] [Abstract][Full Text] [Related]
20. Ex vivo pharmacodynamics of amoxicillin-clavulanate against beta-lactamase-producing Escherichia coli in a yucatan miniature pig model that mimics human pharmacokinetics.
Bronner S; Murbach V; Peter JD; Levêque D; Elkhaïli H; Salmon Y; Dhoyen N; Monteil H; Woodnutt G; Jehl F
Antimicrob Agents Chemother; 2002 Dec; 46(12):3782-9. PubMed ID: 12435677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
